Previous studies have indicated that the E4orf4 protein of human adenovirus type 2 (Ad2) induces p53-independent apoptosis. We believe that this process may play a role in cell death and viral spread at the final stages of productive infection. E4orf4 may also be of therapeutic value in treating some diseases, including cancer, through its ability to induce apoptosis when expressed individually. The only previously identified biochemical function of E4orf4 is its ability to associate with the B␣ subunit of protein phosphatase 2A (PP2A). We have used a genetic approach to determine the role of such interactions in E4orf4-induced cell death. E4orf4 deletion mutants were of only limited value, as all were highly defective. We found that E4orf4 proteins from most if not all adenovirus serotypes induced cell death, and thus point mutations were introduced that converted the majority of highly conserved residues to alanines. Such mutants were used to correlate B␣-subunit binding, association with PP2A activity, and cell killing following the transfection of appropriate cDNAs into p53-null H1299 or C33A cells. The results indicated that binding of the B␣ subunit is essential for induction of cell death, as every mutant that failed to bind efficiently was totally defective for cell killing. This class of mutations (class I) largely involved residues between amino acids 51 and 89. Almost all E4orf4 mutant proteins that associated with PP2A killed cancer cells at high levels; however, several mutants that associated with significant levels of PP2A were defective for killing (class II). Thus, binding of E4orf4 to PP2A is essential for induction of p53-independent apoptosis, but E4orf4 may possess one or more additional functions required for cell killing.Successful, productive infection of human cells by adenoviruses involves a complex interplay between the induction and suppression of apoptosis (43a). Proteins encoded by early region 1A (E1A) transactivate early viral gene expression and stimulate cells to enter S phase to enhance viral DNA synthesis. One consequence of E1A expression by human adenovirus type 5 (Ad5) is the stabilization of p53 (11, 29) resulting from complex formation with members of either the retinoblastoma tumor suppressor or the p300/CBP families of cell cycle regulators (8, 42). Adenoviruses prevent apoptosis or growth arrest by p53 through the action of two E1B products, the 55-kDa protein that binds to and inhibits p53 (51, 58) and the 19-kDa polypeptide that suppresses apoptosis via a mechanism analogous to the cellular Bcl-2 protein (6, 18). The turnover of p53 is also enhanced through the action of complexes between the Ad5 E1B 55-kDa protein and a product of E4, E4orf6 (13, 41). In addition, E1A enhances cell susceptibility to killing by tumor necrosis factor (14,46,57), an effect that is also inhibited by the E1B 19-kDa protein (38, 40) as well as E3 products (reviewed in reference 53).In previous studies it was noted that E1B-defective Ad5 also induces apoptosis in p53-null cells through the...